Biological Safety Testing Market Poised for Strong Growth, Projected to Reach $9 Billion by 2030

 

According to Next Move Strategy Consulting, the global Biological Safety Testing Market is on a remarkable growth trajectory, projected to reach $9 billion by 2030, representing a compound annual growth rate (CAGR) of 10% by 2030. The surge in market growth is attributed to the increasing prevalence of chronic diseases, growth in biopharmaceutical innovations, and rising global regulatory standards aimed at ensuring the safety of biological products.

Download Free Sample: https://www.nextmsc.com/biological-safety-testing-market/request-sample

Understanding Biological Safety Testing

Biological safety testing is a critical process used to assess and confirm the safety of biological products, such as drugs, vaccines, and therapeutics, ensuring that they are free of contamination. These products, often derived from living organisms or their components, must undergo rigorous testing for potential biological hazards, toxicity, and risk characterization before reaching consumers. Such testing is essential to protect human health and the environment, supporting the growing demand for safer and more effective biologic treatments. 

Market Drivers and Trends

The rising prevalence of diseases such as cancer, diabetes, and cardiovascular diseases, particularly among the aging population, is driving the adoption of biologic drugs, subsequently fueling the growth of the biological safety testing market. Biotechnological products require stringent safety testing to ensure they are free of contaminants and safe for human use.

For example, in July 2021, the U.S. FDA approved Semglee, the first interchangeable biologic insulin product for treating Type 1 and Type 2 diabetes, highlighting the increasing importance of biologic therapies. Furthermore, the expansion of the biologics market due to cancer therapies, such as the collaboration between Amgen and Teneobio to develop human heavy-chain antibodies for cancer and autoimmune diseases, is set to propel further market growth.

The increasing approval of biologic drugs and the use of advanced robotics in laboratories for testing are expected to unlock further market opportunities, despite challenges such as the shortage of trained professionals and the lengthy product approval process.

Inquire Before Buying: https://www.nextmsc.com/biological-safety-testing-market/inquire-before-buying

Market Segmentation

The biological safety testing market is segmented into the following categories:

• By Product: Consumables, Kits & Reagents, Instruments, and Services.
• By Test Type: Sterility Tests, Cell Line Authentication & Characterization Tests, Bioburden Tests, Endotoxin Tests, Residual Host Contaminant Detection Tests, and Adventitious Agent Detection Tests.
• By Application: Blood & Blood-Based Products, Cellular and Gene Therapy, Vaccines & Therapeutics, Tissue & Tissue-Related Products Testing, and Stem Cell Research.
• By End User: Contract Development & Manufacturing Organizations (CDMOs), Research & Academia, Pharmaceutical, and Biotechnology Companies.

Geographical Insights

North America currently dominates the biological safety testing market and is expected to continue its growth during the forecast period. The presence of key industry players, including Thermo Fisher Scientific and Charles River Laboratories, along with increasing regulatory measures for biologics, are contributing to market expansion. In 2021, Thermo Fisher introduced the Herasafe 2025 BSC, a biological safety cabinet designed to improve efficiency in biologics testing.

In Asia-Pacific, the market is anticipated to grow steadily due to government initiatives and the increasing demand for regulatory compliance, especially with the rise in cancer cases and the need for safe biologic products. In December 2020, China expanded its biological product inspection guidelines, further driving the demand for biological safety testing.

Competitive Landscape

The biological safety testing market is highly competitive, with significant players such as Charles River Laboratories Inc., Lonza, Thermo Fisher Scientific Inc., Merck KGaA, SGS SA, Eurofins Scientific, WuXiPharmaTech Inc., and Cytovance Biologics Inc.. These companies are leveraging strategies like product innovation and geographical expansion to strengthen their market position. Notably, Lonza introduced the PyroTec PRO Automated Robotic Solution in 2021, which enhances the performance of quality control laboratories by improving efficiency and data integrity in endotoxin testing.

Conclusion

The global biological safety testing market is set for robust growth, driven by increasing demand for biologic products, regulatory requirements, and technological advancements. As more biopharmaceutical companies develop life-saving biologics and as global health challenges increase, the need for rigorous safety testing will continue to surge. Companies in the sector are well-positioned to capitalize on these trends through innovation and strategic expansion.

Also, Browse Related Reports:   

• Argentina In-Vitro Diagnostics Market Outlook – Gain insights into the Argentinian diagnostics market.
• Middle East In-Vitro Diagnostics Market Report – Understand the market growth in the Middle East for diagnostics.
• Thailand In-Vitro Diagnostics Market Trends – Stay ahead with the latest in-vitro diagnostics developments in Thailand.

For more information, please contact:

Next Move Strategy Consulting

E-Mail: info@nextmsc.com

Direct: +1-217-650-7991

Website: www.nextmsc.com

Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube

About Next Move Strategy Consulting:

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.